Aberrant DDX17 expression has been found in hepatocellular carcinoma (HCC), colon cancer, glioma and lung cancer (Xue et al., 2019; Shin et al., 2007; Luo et al., 2020; Li et al., 2017a). Here, DDX17 is linked to hepatocellular carcinoma.